{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:12:03Z","timestamp":1792001523281,"version":"4.4.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19kk0305010"],"award-info":[{"award-number":["JP19kk0305010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Upper urinary tract urothelial carcinoma is a rare cancer that has been associated with mismatch repair genes such as MLH1, MSH2, MSH6 and PMS2. In addition, patients with pathogenic variants of cancer-predisposing genes such as BRCA1 and BRCA2 have been reported. However, how cancer-predisposing genes affect the risk of upper urinary tract urothelial carcinoma in the Japanese population remains unclear. Thus, we performed a case\u2013control sequencing study of 27 cancer-predisposing genes in 208 upper urinary tract urothelial carcinoma patients and 37\u2009727 controls. Only MSH6 and MSH2 were observed with a value of P\u00a0&amp;lt;\u00a00.05. However, there was no difference in the prevalence of pathogenic variants of BRCA1\/2, which does not support the use of a poly adenosine diphosphate-ribose polymerase inhibitor in patients with upper urinary tract urothelial carcinoma. Only mismatch repair genes were associated with patients with upper urinary tract urothelial carcinoma, but the prevalence of pathogenic variants in mismatch repair genes was lower than that reported in previous studies from other populations.<\/jats:p>","DOI":"10.1093\/jjco\/hyac141","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T08:31:10Z","timestamp":1662971470000},"page":"1441-1445","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese"],"prefix":"10.1093","volume":"52","author":[{"given":"Yuya","family":"Sekine","sequence":"first","affiliation":[{"name":"Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences , Kanagawa , Japan"},{"name":"Department of Urology, Akita University Graduate School of Medicine , Akita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences , Kanagawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Hakozaki","sequence":"additional","affiliation":[{"name":"Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences , Kanagawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Endo","sequence":"additional","affiliation":[{"name":"Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences , Kanagawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Kamatani","sequence":"additional","affiliation":[{"name":"Laboratory of Complex Trait Genomics , Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, , Tokyo , Japan"},{"name":"The University of Tokyo , Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Genome Sequencing , Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, , Tokyo , Japan"},{"name":"The University of Tokyo , Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Murakami","sequence":"additional","affiliation":[{"name":"Division of Molecular Pathology , Institute of Medical Science, , Tokyo , Japan"},{"name":"The University of Tokyo , Institute of Medical Science, , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Urology, Kyoto University Graduate School of Medicine , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Department of Urology, Kyoto University Graduate School of Medicine , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1069-2816","authenticated-orcid":false,"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Kyoto University Graduate School of Medicine , Kyoto , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidewaki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences , Kanagawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Numakura","sequence":"additional","affiliation":[{"name":"Department of Urology, Akita University Graduate School of Medicine , Akita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Urology, Akita University Graduate School of Medicine , Akita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Habuchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Akita University Graduate School of Medicine , Akita , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-3504","authenticated-orcid":false,"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[{"name":"Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences , Kanagawa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,10]]},"reference":[{"key":"2022120518091687800_ref1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"2022120518091687800_ref2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"2022120518091687800_ref3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum","volume":"54","author":"Roupr\u00eat","year":"2008","journal-title":"Eur Urol"},{"key":"2022120518091687800_ref4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.19.01395","article-title":"Cancer susceptibility mutations in patients with urothelial malignancies","volume":"38","author":"Carlo","year":"2020","journal-title":"J Clin Oncol"},{"key":"2022120518091687800_ref5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"key":"2022120518091687800_ref6","doi-asserted-by":"crossref","first-page":"175883592097084","DOI":"10.1177\/1758835920970845","article-title":"Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC","volume":"12","author":"Yang","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"2022120518091687800_ref7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jjco\/hyz140","article-title":"Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population","volume":"50","author":"Ito","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"2022120518091687800_ref8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/337944","article-title":"Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant","volume":"70","author":"Berends","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2022120518091687800_ref9","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","article-title":"Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls","volume":"9","author":"Momozawa","year":"2018","journal-title":"Nat Commun"},{"key":"2022120518091687800_ref10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.je.2016.12.003","article-title":"Cross-sectional analysis of BioBank Japan clinical data: a large cohort of 200,000 patients with 47 common diseases","volume":"27","author":"Hirata","year":"2017","journal-title":"J Epidemiol"},{"key":"2022120518091687800_ref11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.je.2016.12.005","article-title":"Overview of the BioBank Japan Project: study design and profile","volume":"27","author":"Nagai","year":"2017","journal-title":"J Epidemiol"},{"key":"2022120518091687800_ref12","article-title":"Population-based Screening for Hereditary Colorectal Cancer Variants in Japan","author":"Fujita","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022120518091687800_ref13","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1158\/0008-5472.CAN-03-2879","article-title":"Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation","volume":"64","author":"Nakagawa","year":"2004","journal-title":"Cancer Res"},{"key":"2022120518091687800_ref14","first-page":"5027","article-title":"Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population","volume":"25","author":"Momozawa","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2022120518091687800_ref15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"2022120518091687800_ref16","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2022120518091687800_ref17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes - association analysis in more than 113,000 Women","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"key":"2022120518091687800_ref18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1382-1","article-title":"Tumour lineage shapes BRCA-mediated phenotypes","volume":"571","author":"Jonsson","year":"2019","journal-title":"Nature"},{"key":"2022120518091687800_ref19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","article-title":"Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants","volume":"8","author":"Momozawa","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/52\/12\/1441\/47588521\/hyac141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/52\/12\/1441\/47588521\/hyac141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:12:28Z","timestamp":1670271148000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/52\/12\/1441\/6695275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,10]]},"references-count":19,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,9,10]]},"published-print":{"date-parts":[[2022,12,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyac141","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,9,10]]}}}